







Please Follow us on Gab, Minds, Telegram, Rumble, Gettr, Truth Social, Twitter, YouTube
Minnesota Children’s Hospital announced that it will temporarily stop administering puberty blockers and cross-sex hormones to minors struggling with gender dysphoria because “recent federal actions” have made vulnerable their doctors’ ability to practice medicine.
It’s clear from the statement released Tuesday that Children’s Minnesota has not acknowledged that experimental medical interventions for children and teens experiencing gender issues can be quite risky to them.
Even with the publication of the U.K.’s Cass report and the U.S. Department of Health and Human Services’ (HHS) report Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices, both spelling out the dangers associated with so-called “gender-affirming care,” the hospital appears to dismiss the possibility that children can be harmed by its methods, stating only that it has “recently experienced an increase in federal actions directed at health systems like ours that provide this care.”
“These actions jeopardize the stability of Minnesota’s only comprehensive pediatric health care system, and they threaten our clinicians’ ability to practice medicine now and in the future,” the statement continues. “If conditions remain the same, we plan to temporarily pause prescribing puberty-suppressing medications and pubertal hormones (estrogen and testosterone) for patients under age 18 in our Gender Health program, effective Friday, Feb. 27, 2026.”
Despite the planned suspension of such medical treatments for minors, Children’s Minnesota wants its followers to know its “Gender Health program is not closed.”
“We continue to provide supportive care, mental health services and guidance regarding medical and non-medical treatment options,” the hospital states, adding it “remains committed to advocating for the patients and families and stand firmly behind the fact that gender affirming care is evidence-based and lifesaving for transgender and gender diverse youth.”
The hospital states it does not “perform gender affirming surgeries.”
HHS announced in December that, pursuant to President Donald Trump’s executive order titled “Protecting Children from Chemical and Surgical Mutilation,” the agency was taking regulatory actions to prohibit federal taxpayer funding to hospitals that perform “sex-rejecting procedures on children — which include puberty blockers, cross-sex hormones, and surgical operations — expose them to irreversible damage, including infertility, impaired sexual function, diminished bone density, altered brain development, and other irreversible physiological effects.”
As Minnesota-based Alpha News reported, the “Minnesota Queer Legislators Caucus” responded on its Facebook account to the hospital’s suspension of its transgender medical treatments for minors.
Referring to the administration of hormone drugs to young children – most of whom are likely to resolve their gender dysphoria experience without medical intervention – as “lifesaving health care,” the caucus statement said that the Trump administration’s investigations into hospitals providing the treatments “are consistent with the Trump administration’s continued use of all available levers to block lifesaving health care and basic human dignity from the trans community.”
“The administration previously pressured hospitals to halt gender-affirming care by executive orders and threats to revoke federal funding,” the queer caucus statement continued, touting that “[t]his pressure campaign worked in many cases, but not in Minnesota.”
“Now, Health and Human Services (HHS)’s threat of investigations marks a new escalation,” the statement continues. “They stem from HHS Secretary Robert F. Kennedy saying that, under his authority, he can unilaterally decide that gender-affirming care — which he calls “sex-rejecting procedures” — is not a safe and effective treatment for trans youth.”
In their official statement, the members of the caucus themselves said “[t]argeting vulnerable trans kids in this way is simply horrific.”
“As a trans refuge state, we refuse to let political bullying put our children at risk,” the lawmakers stated. “The Trump administration and Sec. Kennedy are forcing specialized medical professionals and hospitals into an impossible position. This wave of political extortion efforts creates a dangerous precedent that puts every Minnesotan at risk by prioritizing ideological agendas over the lives of our youngest residents.”
“Gender-affirming care saves lives,” the queer caucus members added. “Our beloved trans community is an integral part of our society, and trans children deserve to become trans adults.”
Referring to the Trump administration’s move to protect children from the transgender medical industry, the lawmakers accused the federal government of “abuse of power and overreach into private medical decisions,” as well as “inhumane targeting of our children—using executive orders, funding threats, and harassment of hospitals and doctors as political leverage—is a violation of human decency.”
“In Minnesota our laws protect our trans youth, their families, and the medical doctors and practitioners who provide health care to them,” the queer caucus said.
The transgender medical complex, nevertheless, appears to be crumbling.
In a position statement published Tuesday, the American Society of Plastic Surgeons (ASPS) said its view of medical interventions for the treatment of gender dysphoria in minors has “evolved” to its new recommendation that plastic surgeons “delay gender-related breast/chest, genital, and facial surgery until a patient is at least 19 years old.”
Citing evidence found in both the Cass report and the HHS report, ASPS asserted the treatment of gender dysphoria in minors requires a “precautionary approach.”
The ASPS position statement came several days after the final verdict in a landmark case in New York State Supreme Court, Westchester County. A jury awarded $2 million to a young woman who filed a malpractice lawsuit against a psychologist and plastic surgeon, alleging they promoted the removal of her healthy breasts when she was 16 years old.
On Wednesday, the New York Times reported that the American Medical Association (AMA) agreed in a statement that, “in the absence of clear evidence,” gender surgery procedures should be delayed until patients become adults.






